Eupraxia Pharmaceuticals Announces Closing of US$63.2 Million Public Offering Including Full Exercise of Underwriter Option

1 month ago

February 20, 2026 15:10 ET  | Source: Eupraxia Pharmaceuticals Inc. VICTORIA, British Columbia, Feb. 20, 2026 (GLOBE NEWSWIRE) -- Eupraxia…

U.S. Food and Drug Administration (FDA) Accepts Tevas New Drug Application (NDA) for Olanzapine Extended-Release Injectable Suspension (TEV-‘749) for the Once-Monthly Treatment of Schizophrenia in Adults

1 month ago

Olanzapine long-acting injectable (LAI) suspension (TEV-'749) has the potential to offer the efficacy of olanzapine in a once-monthly, subcutaneous formulation1If…

LATHAM & WATKINS ELECTS 22 NEW PARTNERS

1 month ago

Promotions from counsel include skilled practitioners advising clients across transactional, litigation, and regulatory matters.NEW YORK, Feb. 20, 2026 /PRNewswire/ --…

VERSES Announces Filing of Quarterly Report on Form 10-Q for the Three and Nine-Months Ended December 31, 2025

1 month ago

February 20, 2026 19:11 ET  | Source: VERSES AI Inc. VANCOUVER, British Columbia, Feb. 20, 2026 (GLOBE NEWSWIRE) -- VERSES…

Constellation Software Inc. Announces Change to the Date of the Conference Call to Discuss Fourth Quarter Results

1 month ago

February 20, 2026 17:16 ET  | Source: Constellation Software Inc. TORONTO, Feb. 20, 2026 (GLOBE NEWSWIRE) -- Constellation Software Inc.…

Bel Fuse Inc. Announces Regular Quarterly Cash Dividend on its Class A and Class B Shares

1 month ago

February 20, 2026 16:49 ET  | Source: Bel Fuse Inc. WEST ORANGE, N.J., Feb. 20, 2026 (GLOBE NEWSWIRE) -- BEL…

Trinity Biotech Receives Non-Compliance Notice Regarding Nasdaq Global Select Requirement for Minimum Market Value of Publicly Held Shares

1 month ago

DUBLIN, Feb. 20, 2026 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics…

Amicus Therapeutics Announces Full-Year 2025 Financial Results and Corporate Updates

1 month ago

2025 Total Revenue of $634M, up 17% Year-over-Year at CER Cash Position of $294M, a $44M Increase in 2025 Proposed…

aTyr Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

1 month ago

SAN DIEGO, Feb. 20, 2026 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: ATYR) (“aTyr” or “the Company”), a clinical stage…

Not sure how to give wishes for the Year of the Horse? Let’s hear from CGs in Guangzhou

1 month ago

GUANGZHOU, China, Feb. 20, 2026 /PRNewswire/ -- A news report from South:   As we gallop into the Year of…